Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pulmonary fibrosis: A short- or long-term sequelae of severe COVID-19?
Zhen Zheng, Fei Peng, Yong Zhou
Chinese Medical Journal - Pulmonary and Critical Care Medicine (2023) Vol. 1, Iss. 2, pp. 77-83
Open Access | Times Cited: 22

Showing 22 citing articles:

Biomarkers in idiopathic pulmonary fibrosis: Current insight and future direction
Zhen Zheng, Fei Peng, Yong Zhou
Chinese Medical Journal - Pulmonary and Critical Care Medicine (2024) Vol. 2, Iss. 2, pp. 72-79
Open Access | Times Cited: 9
Persisting Shadows: Unraveling the Impact of Long COVID-19 on Respiratory, Cardiovascular, and Nervous Systems
Christina-Michailia Sideratou, Christos Papaneophytou
Infectious Disease Reports (2023) Vol. 15, Iss. 6, pp. 806-830
Open Access | Times Cited: 16
Post‐COVID‐19 pulmonary fibrosis: Mechanisms, biomarkers, and therapeutic perspectives
Urvinder Kaur Sardarni, Siddappa N. Byrareddy
Clinical and Translational Discovery (2025) Vol. 5, Iss. 1
Open Access
Morphopathology of the lesions induced by SARS-CoV-2 infection in the lungs
Florin Ionuţ Buibaş, Roberta Andreea Cercel, Mircea-Sebastian Șerbănescu, et al.
Romanian Journal of Morphology and Embryology (2025) Vol. 65, Iss. 4, pp. 637-645
Open Access
New evidence for T-cadherin in COVID-19 pathogenesis, endothelial dysfunction, and lung fibrosis
Е. В. Семина, Vladimir Popov, Nikita R. Khabibullin, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Pharmacological approaches to pulmonary fibrosis following COVID-19
Štefan Laššán, Tomáš Tesař, J Tisonová, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 11
COVID-19: A threat to the respiratory system
Ghulam Rasool, Waqas Khan, Arif Khan, et al.
International Journal of Immunopathology and Pharmacology (2024) Vol. 38
Open Access | Times Cited: 2
Longitudinal Analysis of Pulmonary Function Impairment One Year Post-COVID-19: A Single-Center Study
Noemi Suppini, Ovidiu Fira-Mlădinescu, Daniel Trăilă, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 8, pp. 1190-1190
Open Access | Times Cited: 5
Molecular Regulation of Transforming Growth Factor-β1-induced Thioredoxin-interacting Protein Ubiquitination and Proteasomal Degradation in Lung Fibroblasts: Implication in Pulmonary Fibrosis
Sarah Taleb, Qinmao Ye, Boina Baoyinna, et al.
Deleted Journal (2024) Vol. 1, Iss. 1, pp. 10002-10002
Open Access | Times Cited: 1
Loss of ZNF451 mediates fibroblast activation and promotes lung fibrosis
Hong Peng, Yu Shrike Zhang, Jiali Min, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Effect of apigetrin in pseudo-SARS-CoV-2-induced inflammatory and pulmonary fibrosis in vitro model
Hengmin Han, Jung-Eun Kim, Hyo‐Jeong Lee
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Persistent Health and Cognitive Impairments Up to Four Years Post-COVID-19 in Young Students: The Impact of Virus Variants and Vaccination Timing
Ashkan Latifi, Jaroslav Flegr
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Sinomenine ameliorates bleomycin-induced pulmonary fibrosis by inhibiting the differentiation of fibroblast into myofibroblast
Zuqiong Nie, Jing Wu, Jun Xie, et al.
Heliyon (2024) Vol. 10, Iss. 13, pp. e33314-e33314
Open Access
Timeline of the pandemic: epidemiology, global spread, variants and waves
Yue-Xing Liu, Junyu Luo, Ruibin Liu, et al.
European Respiratory Society eBooks (2024)
Closed Access
STAT5-c-Myc-axis regulates the difference of B cell metabolism between vaccinated population and recovered COVID-19 patients
Yang Lu, Linghua Wang, Qian Liu, et al.
Authorea (Authorea) (2024)
Open Access
Polyphyllin VI Ameliorates Pulmonary Fibrosis by Suppressing the MAPK/ERK and PI3K/AKT Signaling Pathways via Upregulating DUSP6
Yuting Xie, Cailing Gan, Hongyao Liu, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 12, pp. 5930-5948
Closed Access
Prognostic Implications of Initial Radiological Findings of Pulmonary Fibrosis in Patients with Acute SARS-CoV-2 Infection: A Prospective Multicentric Study
Roxana-Elena Cîrjaliu, Sri Vidhya Gurrala, Balaji Nallapati, et al.
Diseases (2024) Vol. 12, Iss. 11, pp. 285-285
Open Access
Efficacy of azvudine plus dexamethasone in severe hospitalized patients with Omicron infection: a prospective multicenter study
Menglan Zhang, Xiaoying Wei, Nan Su, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access
Lung-resident lymphocytes and their roles in respiratory infections and chronic respiratory diseases
Arka Sen Chaudhuri, Jie Sun
Chinese Medical Journal - Pulmonary and Critical Care Medicine (2024) Vol. 2, Iss. 4, pp. 214-223
Open Access
Persistent Health and Cognitive Impairments Up to Four Years Post-COVID-19 in Young Students: The Impact of Virus Variants and Vaccination Timing
Ashkan Latifi, Jaroslav Flegr
Biomedicines (2024) Vol. 13, Iss. 1, pp. 69-69
Open Access
Effects of acute-phase COVID-19-related indicators on pulmonary fibrosis and follow-up evaluation
Q. Wang, Ying Zhou, Fangxue Jing, et al.
Research Square (Research Square) (2024)
Open Access
Effects of acute-phase COVID-19-related indicators on pulmonary fibrosis and follow-up evaluation
Q. Wang, Ying Zhou, Fangxue Jing, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access
Page 1

Scroll to top